【24h】

In?Vivo Tissue Engineering of Human?Airways

机译:人体航空体内组织工程

获取原文
           

摘要

Background Airway transplantation remains a major challenge in thoracic surgery. Based on our previous laboratory work, we developed the techniques required to bioengineer a tracheal substitute in?vivo using cryopreserved aortic allografts as biological matrices (Replacement of the Airways and/or the Pulmonary Vessels Using a Cryopreserved Arterial Allograft [TRACHEOBRONCART] Study, NCT01331863). We present here 2 patients who had a definitive tracheostomy for complex laryngotracheal stenoses refractory to conventional therapy.;Methods According to our protocol, a stented gender-mismatched –80°C cryopreserved aortic allograft was used for airway reconstruction. Follow-up assessments were done at regular intervals using clinical, imaging, and endoscopic evaluations. Immunohistochemical and XX/XY chimerism studies were performed at time of stent removal using graft biopsy specimens. Chemotactic and angiogenic properties of implanted matrices were also investigated.;Results At a maximal follow-up of 5 years and 7 months, the patients were breathing and speaking normally, without tracheostomy or stent. Regeneration of cartilage within the aortic grafts was demonstrated by positive immunodetection of type II collagen and markers specific for Sox9. Chimerism study from samples of neotissues demonstrated that regenerated cartilage came from recipient cells. The remaining viable matrix cells released a functionally relevant amount of proangiogenic, chemoattractant, proinflammatory/immunomodulatory cytokines, and growth factors.;Conclusions This report documents the feasibility of in?vivo tissue engineering for long-term functional airway transplantation in humans.;;The Supplemental MaterialsSupplemental Materials can be viewed in the online version of this article [http://dx.doi.org/10.1016/j.athoracsur.2016.11.027] on http://www.annalsthoracicsurgery.org.;Jump to SectionPatients and MethodsPatientsSurgical Procedure and Follow-upImmunohistochemical and XX/XY Chimerism StudiesCharacteristics of the Implanted CAA MatrixResultsClinical AspectsBiological AspectsCommentSupplementary DataReferences;The medical history, preoperative findings, and demographics?of the 2 patients are summarized in Table?1Table?1. A complex benign postintubation laryngotracheal stenosis associated with severe underlying general or local diseases, or both, had developed in both patients. They underwent multiple previous airway interventions for upper tracheal stenosis using conventional surgical and bronchoscopic management, which resulted in the extension of the stenoses to the subglottic larynx. Facing a therapeutic dead end, the placement of a permanent airway T-tube through a tracheostomy was performed (Supplemental Fig S1A–ESupplemental Fig S1A–E).Table?1Medical History, Preoperative and Perioperative Characteristics, and Follow-Up of the 2 PatientsCharacteristicPatient 1Patient 2GenderFemaleMaleAge, y5833Underlying general or local diseasesIdiopathic laryngeal edemaSevere epilepsy controlled by 4?drugsAirway intubation?CauseThyroidectomy for Basedow diseaseRefractory epileptic seizure?Duration4 hours1 week?Year19982009Airway stenosis siteLaryngotrachealLaryngotrachealPrevious SM?Number of attempts11?Month and yearJune 2010April 2009?Cause of failureUpper airway malaciaAnastomotic dehiscencePrevious EM?Attempts, No.13?Month and yearJune 2010April–Sept 2009?Cause of failureLaryngeal edemaStent migrationPreoperative pulmonary function tests?FEV1 (% predicted value)75NA?FIV1 (% predicted value)70NAPreoperative SGRQ?Total score (%)2,776.29 (70)193.04 (29)?Symptoms (%)410.26 (62)1,204.6 (100)?Activity (%)898.1 (74)1,584.63 (75)?Impact (%)1,467.93 (69)1,584.63 (75)Referred from another centerNoYesIntensive preoperative cardiorespiratory training,?wk33Date of operationOctober 2010October 2011Sex mismatch (D/R)YesYesLength of the graft, cm55Perioperative difficultiesNoNoPostoperative courseUneventfulUneventfulDays of hospitalization1410Removal of cannulaa21Local ev
机译:背景技术气道移植仍然是胸外科中的主要挑战。在之前的实验室工作的基础上,我们开发了将冷冻的主动脉同种异体移植物用作生物基质进行气管内替代物生物工程化所需的技术(使用冷冻的同种异体移植物置换气道和/或肺血管[TRACHEOBRONCART]研究,NCT01331863) 。我们在此介绍2例因常规治疗难治的复杂性喉气管狭窄的气管造口术患者。方法根据我们的方案,将支架置入性别不匹配的–80°C冷冻保存的主动脉同种异体移植物用于气道重建。定期使用临床,影像和内窥镜评估进行随访评估。免疫组织化学和XX / XY嵌合研究是在使用移植物活检标本取出支架时进行的。结果还观察了植入基质的趋化和血管生成特性。结果在最长随访5年和7个月时,患者呼吸和说话正常,无气管切开术或支架。 II型胶原蛋白和对Sox9特异的标记物的阳性免疫检测证明了主动脉移植物中软骨的再生。从新组织样本进行的嵌合研究表明,再生软骨来自受体细胞。其余的存活基质细胞释放了功能相关的促血管生成素,化学引诱剂,促炎/免疫调节细胞因子和生长因子。结论结论本报告证明了体内组织工程技术在人类长期功能性气道移植中的可行性。补充材料可以在http://www.annalsthoracicsurgery.org。上的本文在线版本[http://dx.doi.org/10.1016/j.athoracsur.2016.11.027]中查看;跳至部分患者和方法患者的手术方法和随访免疫组化和XX / XY嵌合体研究植入的CAA基质的特征结果临床方面生物方面评论补充数据参考; 2例患者的病史,术前发现和人口统计学总结于表1表1。两名患者均出现了与严重的潜在的一般或局部疾病或两者相关的复杂的良性插管后喉气管狭窄。他们使用传统的外科手术和支气管镜治疗方法对先前的上气管狭窄进行了多次气道干预,从而使狭窄部位扩展到了声门下喉。面对治疗的死胡同,通过气管切开术进行了永久性气道T形管的放置(补充图S1A-E补充图S1A-E)。表1 2例患者的病史,术前和围手术期特征以及随访1Patient 2GenderFemaleMaleAge,y5833Underlying 4?drugsAirway插管?CauseThyroidectomy为巴塞diseaseRefractory癫痫发作?Duration4小时1星期?Year19982009Airway狭窄siteLaryngotrachealLaryngotrachealPrevious SM?attempts11的号码?月和yearJune 2010April 2009年?原因failureUpper呼吸道malaciaAnastomotic dehiscencePrevious控制的全身或局部diseasesIdiopathic喉edemaSevere癫痫EM?尝试次数,No.13?2010年6月和2009年4月至2009年9月?失败的原因喉水肿支架迁移术前肺功能检查?FEV1(预测值%)75NA?FIV1(预测值%)70NA术前SGRQ?总分(%)2,776.29(70) )193.04(29)?症状(%)410.26(62 )1,204.6(100)活动(%)898.1(74)1,584.63(75)影响(%)1,467.93(69)1,584.63(75)参考另一中心否是强化术前心肺训练,wk33手术日期2010年10月2011年10月/性别不匹配(D是是移植长度55厘米手术困难否否术后疗程不变不变不变住院天数1410拔除套管21局部ev

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号